TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $4.64B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alaunos Therapeutics USD 53M 48M Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
Ardelyx USD 1.32B 100M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
Bayer EUR 38.45B 2.09B Mar/2026
Biogen USD 25.82B 5.28B Dec/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Infinity Pharmaceuticals USD 19M 5M Jun/2023
J&J USD 500.24B 67.44B Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
Novavax USD 1.43B 340M Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025